| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 22 | 2022 | 95 | 5.580 |
Why?
|
| HIV-1 | 25 | 2017 | 456 | 3.780 |
Why?
|
| HIV Infections | 23 | 2022 | 886 | 2.990 |
Why?
|
| Simian Immunodeficiency Virus | 5 | 2022 | 23 | 2.520 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2022 | 25 | 2.310 |
Why?
|
| Viral Regulatory and Accessory Proteins | 9 | 2016 | 13 | 2.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 16 | 2016 | 224 | 2.080 |
Why?
|
| Histocompatibility Antigens Class I | 6 | 2016 | 20 | 1.420 |
Why?
|
| Human Immunodeficiency Virus Proteins | 5 | 2016 | 5 | 1.280 |
Why?
|
| T-Lymphocytes | 10 | 2016 | 223 | 1.170 |
Why?
|
| Cytokines | 4 | 2022 | 351 | 1.150 |
Why?
|
| Antigens, CD | 8 | 2012 | 101 | 1.110 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2016 | 2 | 1.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2022 | 178 | 1.070 |
Why?
|
| Lymphocytes | 3 | 2021 | 111 | 1.030 |
Why?
|
| HLA-C Antigens | 4 | 2016 | 10 | 0.970 |
Why?
|
| Down-Regulation | 5 | 2016 | 114 | 0.920 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 5 | 2016 | 8 | 0.880 |
Why?
|
| Interferon-gamma | 5 | 2022 | 111 | 0.810 |
Why?
|
| Colon | 5 | 2022 | 163 | 0.720 |
Why?
|
| HIV | 4 | 2007 | 83 | 0.670 |
Why?
|
| Lymphocyte Activation | 7 | 2017 | 217 | 0.640 |
Why?
|
| Cytotoxicity, Immunologic | 6 | 2010 | 31 | 0.630 |
Why?
|
| Immunity, Innate | 6 | 2022 | 98 | 0.620 |
Why?
|
| Virus Replication | 8 | 2008 | 93 | 0.610 |
Why?
|
| Macaca mulatta | 3 | 2022 | 68 | 0.580 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 232 | 0.570 |
Why?
|
| Receptors, Virus | 1 | 2016 | 7 | 0.550 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 48 | 0.510 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 22 | 0.490 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 2 | 0.490 |
Why?
|
| Receptors, Natural Killer Cell | 4 | 2022 | 5 | 0.490 |
Why?
|
| Humans | 42 | 2021 | 31059 | 0.460 |
Why?
|
| Lymphocyte Subsets | 3 | 2014 | 30 | 0.450 |
Why?
|
| Receptors, Immunologic | 3 | 2007 | 36 | 0.420 |
Why?
|
| Animals | 12 | 2022 | 4713 | 0.400 |
Why?
|
| Cell Degranulation | 1 | 2010 | 7 | 0.370 |
Why?
|
| Granzymes | 2 | 2021 | 7 | 0.370 |
Why?
|
| Salmonella typhimurium | 3 | 2021 | 4 | 0.350 |
Why?
|
| Inflammation | 3 | 2022 | 361 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 234 | 0.350 |
Why?
|
| Gene Products, vpr | 1 | 2009 | 1 | 0.350 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 17 | 0.340 |
Why?
|
| Membrane Glycoproteins | 4 | 2007 | 107 | 0.340 |
Why?
|
| Interleukins | 2 | 2020 | 38 | 0.340 |
Why?
|
| Macrophages | 4 | 2000 | 137 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 209 | 0.310 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 2007 | 12 | 0.310 |
Why?
|
| HLA Antigens | 2 | 2004 | 18 | 0.300 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 5 | 0.300 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 7 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 15 | 0.290 |
Why?
|
| HLA-B Antigens | 4 | 2016 | 11 | 0.290 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 40 | 0.290 |
Why?
|
| Melphalan | 6 | 1991 | 16 | 0.290 |
Why?
|
| Flow Cytometry | 6 | 2017 | 204 | 0.290 |
Why?
|
| Genetic Vectors | 3 | 2006 | 63 | 0.280 |
Why?
|
| Transcription Factors | 1 | 2007 | 171 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 286 | 0.270 |
Why?
|
| Stress, Psychological | 2 | 2018 | 254 | 0.250 |
Why?
|
| Immunity, Cellular | 5 | 2007 | 63 | 0.250 |
Why?
|
| Cell Line | 7 | 2010 | 304 | 0.250 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2015 | 39 | 0.240 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 3 | 2010 | 3 | 0.240 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 3 | 2010 | 4 | 0.240 |
Why?
|
| Interleukin-2 | 4 | 2008 | 69 | 0.220 |
Why?
|
| Plasmacytoma | 5 | 1991 | 19 | 0.220 |
Why?
|
| Cells, Cultured | 9 | 2016 | 686 | 0.220 |
Why?
|
| Cullin Proteins | 2 | 2015 | 2 | 0.220 |
Why?
|
| GPI-Linked Proteins | 4 | 2014 | 27 | 0.210 |
Why?
|
| B7-1 Antigen | 2 | 1999 | 12 | 0.210 |
Why?
|
| Th17 Cells | 1 | 2022 | 29 | 0.200 |
Why?
|
| Ruminococcus | 1 | 2021 | 2 | 0.190 |
Why?
|
| Acinetobacter | 1 | 2021 | 2 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2021 | 11 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 4 | 1999 | 271 | 0.180 |
Why?
|
| Interleukin-17 | 1 | 2020 | 30 | 0.180 |
Why?
|
| DNA Damage | 2 | 2010 | 31 | 0.180 |
Why?
|
| Ligands | 3 | 2014 | 57 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2019 | 58 | 0.170 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 17 | 0.170 |
Why?
|
| Gram-Negative Bacteria | 1 | 2019 | 37 | 0.160 |
Why?
|
| Chemokines, CC | 2 | 1998 | 8 | 0.160 |
Why?
|
| Underage Drinking | 1 | 2018 | 1 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 1 | 0.160 |
Why?
|
| CD28 Antigens | 1 | 1998 | 18 | 0.160 |
Why?
|
| HIV Long-Term Survivors | 1 | 1998 | 10 | 0.160 |
Why?
|
| Tobacco Use | 1 | 2018 | 7 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 93 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 58 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 79 | 0.150 |
Why?
|
| Receptors, CCR7 | 2 | 2015 | 7 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 60 | 0.150 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 32 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2018 | 132 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 93 | 0.150 |
Why?
|
| Conduct Disorder | 1 | 2017 | 1 | 0.150 |
Why?
|
| Facial Expression | 1 | 2017 | 16 | 0.150 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 31 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 35 | 0.140 |
Why?
|
| Dysbiosis | 1 | 2017 | 72 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2009 | 185 | 0.140 |
Why?
|
| HIV-2 | 1 | 1996 | 11 | 0.140 |
Why?
|
| Emotions | 1 | 2017 | 89 | 0.140 |
Why?
|
| Social Environment | 1 | 2017 | 87 | 0.140 |
Why?
|
| Cell Death | 1 | 2016 | 61 | 0.140 |
Why?
|
| Receptors, KIR3DL1 | 1 | 2016 | 2 | 0.140 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2016 | 1 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1994 | 35 | 0.130 |
Why?
|
| Th2 Cells | 1 | 1995 | 28 | 0.130 |
Why?
|
| Th1 Cells | 1 | 1995 | 34 | 0.130 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 83 | 0.130 |
Why?
|
| Female | 11 | 2020 | 17005 | 0.130 |
Why?
|
| Peptides | 1 | 2016 | 97 | 0.120 |
Why?
|
| Cell Movement | 2 | 2014 | 105 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 18 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2014 | 103 | 0.120 |
Why?
|
| Male | 8 | 2020 | 16488 | 0.120 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1994 | 7 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2006 | 18 | 0.120 |
Why?
|
| Lentivirus | 2 | 2006 | 13 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2014 | 62 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2012 | 38 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2012 | 6 | 0.110 |
Why?
|
| Immunophenotyping | 2 | 2014 | 86 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2012 | 69 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1321 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2012 | 144 | 0.100 |
Why?
|
| Gangliosides | 1 | 1991 | 6 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 1991 | 20 | 0.090 |
Why?
|
| Jurkat Cells | 1 | 2010 | 13 | 0.090 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1991 | 28 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2010 | 52 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 3 | 1996 | 99 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2009 | 14 | 0.090 |
Why?
|
| Neoplasms, Experimental | 2 | 1990 | 11 | 0.090 |
Why?
|
| B7-2 Antigen | 2 | 1999 | 7 | 0.080 |
Why?
|
| CD3 Complex | 2 | 1999 | 15 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 159 | 0.080 |
Why?
|
| Stem Cells | 1 | 2009 | 49 | 0.080 |
Why?
|
| Viremia | 2 | 2007 | 36 | 0.080 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 61 | 0.080 |
Why?
|
| Mice | 8 | 2006 | 1681 | 0.080 |
Why?
|
| Apoptosis | 1 | 2010 | 260 | 0.080 |
Why?
|
| Antigens, Ly | 1 | 1988 | 2 | 0.080 |
Why?
|
| Monocytes, Activated Killer | 1 | 2008 | 1 | 0.080 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 1998 | 9 | 0.080 |
Why?
|
| Gene Expression | 1 | 2009 | 239 | 0.080 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 13 | 0.080 |
Why?
|
| Chemokine CCL5 | 2 | 1998 | 17 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2007 | 37 | 0.070 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2007 | 1 | 0.070 |
Why?
|
| CD48 Antigen | 1 | 2007 | 3 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2007 | 46 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 6 | 1991 | 271 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 1800 | 0.070 |
Why?
|
| Time Factors | 3 | 2004 | 1679 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2006 | 4 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 164 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1998 | 11 | 0.060 |
Why?
|
| Viral Load | 2 | 2012 | 195 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2004 | 11 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 19 | 0.060 |
Why?
|
| HIV Core Protein p24 | 2 | 2008 | 29 | 0.060 |
Why?
|
| Receptors, KIR | 1 | 2004 | 2 | 0.060 |
Why?
|
| K562 Cells | 1 | 2004 | 6 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 14 | 0.060 |
Why?
|
| Disease Progression | 2 | 1998 | 832 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 195 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 246 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 13 | 0.050 |
Why?
|
| Cell Separation | 1 | 2003 | 43 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2003 | 52 | 0.050 |
Why?
|
| Spleen | 4 | 1990 | 55 | 0.050 |
Why?
|
| Middle Aged | 5 | 2014 | 10235 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 2400 | 0.050 |
Why?
|
| Adult | 4 | 2014 | 8945 | 0.050 |
Why?
|
| Chemokine CCL4 | 2 | 1998 | 8 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 1998 | 35 | 0.050 |
Why?
|
| Gene Products, tax | 1 | 2000 | 2 | 0.050 |
Why?
|
| Silicosis | 1 | 2000 | 1 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 22 | 0.040 |
Why?
|
| Mast Cells | 1 | 2000 | 25 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 17 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2019 | 28 | 0.040 |
Why?
|
| Microglia | 1 | 2000 | 132 | 0.040 |
Why?
|
| Isoantibodies | 2 | 1989 | 11 | 0.040 |
Why?
|
| Astrocytes | 1 | 2000 | 127 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 36 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 256 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1998 | 2 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 31 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 1998 | 31 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 108 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 76 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 59 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 236 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 14 | 0.040 |
Why?
|
| Monocytes | 2 | 2000 | 115 | 0.040 |
Why?
|
| Carrageenan | 2 | 1988 | 2 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 1988 | 23 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 41 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2017 | 21 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 1998 | 334 | 0.040 |
Why?
|
| Graft Rejection | 2 | 1988 | 75 | 0.040 |
Why?
|
| Superinfection | 1 | 1996 | 1 | 0.040 |
Why?
|
| Amygdala | 1 | 2017 | 50 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2017 | 83 | 0.040 |
Why?
|
| CD8 Antigens | 2 | 1994 | 18 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 97 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 167 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 427 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 215 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1995 | 35 | 0.030 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 1995 | 39 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 28 | 0.030 |
Why?
|
| CD4 Antigens | 1 | 2015 | 37 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1991 | 17 | 0.030 |
Why?
|
| Reference Values | 2 | 2000 | 231 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 22 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 18 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 63 | 0.030 |
Why?
|
| Protein Binding | 1 | 2014 | 125 | 0.030 |
Why?
|
| Chemokine CCL19 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2012 | 135 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1006 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 70 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 21 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1991 | 27 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2006 | 34 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1994 | 89 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 5 | 0.030 |
Why?
|
| Virus Release | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 46 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 75 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2012 | 178 | 0.030 |
Why?
|
| Thymoma | 2 | 1991 | 13 | 0.020 |
Why?
|
| Chimera | 1 | 1991 | 5 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1991 | 22 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 37 | 0.020 |
Why?
|
| Granulocytes | 1 | 1991 | 23 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1991 | 46 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1988 | 38 | 0.020 |
Why?
|
| Aged | 2 | 2000 | 10077 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2057 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 204 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1987 | 6 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 1987 | 14 | 0.020 |
Why?
|
| Retina | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 28 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 59 | 0.020 |
Why?
|
| Injections | 1 | 2006 | 57 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 36 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 464 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 9 | 0.010 |
Why?
|
| Lymphocyte Depletion | 2 | 1991 | 6 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 249 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1991 | 443 | 0.010 |
Why?
|
| Lung | 1 | 2000 | 173 | 0.010 |
Why?
|
| Zidovudine | 1 | 1996 | 40 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1729 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 149 | 0.010 |
Why?
|
| Ionomycin | 1 | 1991 | 3 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1991 | 66 | 0.010 |
Why?
|
| Phagocytes | 1 | 1991 | 24 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 5196 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1990 | 20 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1990 | 36 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 1989 | 2 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1990 | 69 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1990 | 322 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 386 | 0.010 |
Why?
|